Rollover equity in a dental practice sale is the portion of the purchase price paid in shares of the buyer’s parent company or the local joint venture instead of cash. It is illiquid, junior to platform debt, and typically realized only when the sponsor recapitalizes or sells, often three to seven years after closing.
Key Takeaways
- Headline prices can be misleading. A DSO offer usually needs adjustment for taxes on cash, equity risk, and years of required post-close clinical work.
- DSO deals typically deliver 60–75% cash at close with 15–30% rollover equity that can remain illiquid for three to seven years, while private-buyer offers usually provide 80–100% cash with only a four-to-eight-week transition.
- Three adjustments, tax on cash, discount for equity risk, and cost of the work-back, can shrink or reverse the apparent gap between a $3.4 million DSO offer and a $3.0 million all-cash private offer.
- Before accepting rollover equity, sellers should underwrite its class, valuation, liquidity triggers, vesting and forfeiture terms, and tax-deferral eligibility to reduce unexpected tax or loss exposure.
- McLerran & Associates produces multi-year, multi-structure financial forecasting and runs a competitive auction process that typically generates around 10 offers and improves cash-at-close for sellers.
Schedule a free, confidential discovery call with McLerran & Associates.
How To Read The Two Structures Side By Side
Every dental practice offer has five moving parts: cash at close, equity, earnout, work-back, and valuation basis. Private buyers, meaning individual dentists, typically value a practice as a percentage of collections or a multiple of seller’s discretionary earnings (SDE, the owner’s total economic benefit from the practice before debt service). DSOs and private equity-backed platforms value on EBITDA, which is earnings before interest, taxes, depreciation, and amortization, calculated after paying every dentist, including the owner, a market associate rate.
Those two methods can produce very different numbers for the same practice, so headline figures are rarely directly comparable. In a DSO deal, cash at close typically runs 60–75% of total consideration, with 15–30% rollover equity and 5–15% earnout tied to retained EBITDA over 12–36 months. As much as 40% of a DSO deal can be paid in equity rather than cash.
The equity can sit at two levels. Joint-venture equity in the doctor’s home practice may pay distributions and often carries a higher floor but a lower ceiling. Holding-company equity in the parent DSO usually pays no distributions but can have a higher ceiling if the platform performs well. A private doctor-to-doctor walk-away sale, by contrast, typically delivers close to 100% cash at closing with a work-back of roughly four to eight weeks. The table below summarizes how the two structures compare across the four main deal components.
| Deal Component | All-Cash Private Buyer | DSO Cash + Rollover Equity |
|---|---|---|
| Cash at closing | ~80–100% of price | ~60–75% of price |
| Equity | None | ~15–30% rollover, illiquid 3–7 years |
| Earnout | Rare | ~5–15%, tied to 12–36 month targets |
| Work-back | ~4–8 weeks | ~3–6 years |
The private-buyer column reflects a doctor-to-doctor walk-away sale. A DSO’s higher headline multiple can still produce a weaker outcome. An offer at 9x EBITDA with 65% cash and a three-year earnout may be less attractive than a private buyer offering 7x with 95% cash.
How To Run The Two-Offer Math: A Worked Comparison
The following figures are illustrative. Every seller’s numbers differ based on practice size, tax situation, state of residence, and deal structure. This example shows the framework and does not predict any specific outcome.
Consider a $3.0 million all-cash offer from a private dentist versus a $3.4 million DSO offer structured as 70% cash and 30% rollover equity. The DSO offer resolves to roughly $2.38 million cash at close and roughly $1.02 million in illiquid equity. Before the owner compares those figures to the private-buyer offer, three adjustments are required.
First, subtract estimated tax on the cash portion. The allocation of the purchase price across asset classes, goodwill, equipment, and non-compete, determines how much is taxed at long-term capital gains rates versus ordinary income. More than 76% of the dental practice purchase price typically flows to goodwill. Goodwill is generally taxed at long-term capital gains rates of 20% federal plus 3.8% net investment income tax. Equipment recapture and non-compete allocations are taxed as ordinary income at rates up to 37%. State tax adds further variation, so a qualified tax advisor should model your specific situation.
Second, discount the equity for illiquidity and subordination. The $1.02 million in rollover equity is not $1.02 million in hand. It represents the owner’s own money reinvested at risk in a private, sponsor-backed platform, junior to whatever debt the platform carries, with liquidity controlled by the sponsor’s timetable rather than the seller’s. Rollover equity can behave like a long-dated speculative asset that might be worth 1.5 to 3 times the initial roll if the group performs, or potentially worth zero if the group struggles.
Third, price the work-back. A DSO deal typically requires three to six years of continued clinical work. Divide the total after-tax proceeds by the hours of post-close clinical work plus the years of lost autonomy. Then compare that effective hourly return to what the owner would earn keeping the practice or accepting the private-buyer offer with its four-to-eight-week transition.
Once those three adjustments are applied, the headline gap between $3.4 million and $3.0 million frequently shrinks or inverts. McLerran & Associates produces multi-year, multi-structure financial forecasting and cash-flow modeling across 3-, 5-, 7-, and 10-year horizons, including conservative recapitalization assumptions, so the owner compares real after-tax cash rather than headline price. For more on how dental practice transitions are valued, see Dental Practice Transition Valuation: Methods Explained.
How To Underwrite The Rollover Equity You Are Being Asked To Take
The equity component of a DSO offer represents the owner’s own money reinvested into a private platform alongside a private equity sponsor. Before accepting any rollover, the seller should work through five underwriting questions.
- What am I receiving? Determine whether the rollover is common equity, preferred equity, or a subordinated class, and at which entity level, the joint venture or the holding company. The answers shape your rights relative to the sponsor, including how you share distributions, what debt sits above you, and how future dilution could reduce your stake.
- How is it valued? Confirm the multiple used to set the equity value at close and who controls future valuations at exit. Control over valuation can be some of the main factors that determine your eventual payout.
- When can I sell? Identify what triggers liquidity, such as a recapitalization, a sale, or an IPO, and who controls the timing. DSO equity rollover is typically illiquid until a DSO recapitalization or IPO, with timing controlled by the sponsor rather than the seller.
- What happens if I leave? Review vesting schedules, forfeiture provisions, repurchase rights, and clawback terms. A dentist who leaves a DSO early typically forfeits unvested rollover equity and may owe a clawback on part of the initial cash payment.
- What do I net after tax? Determine whether the rollover qualifies for tax deferral under IRC §351 or §721. Skipping tax structuring at the LOI stage often disqualifies the roll from deferral treatment, shifting 20% to 40% of the roll value to current-year tax burden.
The seller’s equity sits junior to platform debt. The drag-along and liquidity mechanics in the equityholders’ agreement matter as much as the headline multiple. These documents should be reviewed as an interconnected package, including the purchase agreement, employment agreement, rollover equity documents, and management services agreement, before signing anything.
Get a confidential review of your offer before you sign.
How To Negotiate Earnout Terms That Are Not Punitive
An earnout is a deferred payment, typically 5–15% of consideration, tied to retained EBITDA or collections over 12–36 months, used to bridge a valuation gap between what the seller believes the practice is worth and what the buyer is willing to pay at close. Earnouts are common in DSO deals and rare in private doctor-to-doctor sales.
Two terms can make an earnout less punitive. First, pro-rata provisions ensure that a near-miss on an EBITDA target still pays most of the earnout rather than forfeiting it entirely. Buyers often set earnout hurdles at levels the practice would need heroic growth to hit, then keep 20% to 30% of promised purchase price unpaid. Sellers should negotiate hurdles that reflect actual trailing performance. Second, a later start date, beginning the earnout measurement period after integration is complete rather than on the day of closing, can protect the seller from performance disruptions caused by the buyer’s own transition activities.
The metric itself matters as much as the threshold. An earnout measured on practice profitability after the management fee is deducted means the seller who has not negotiated the management fee has not negotiated the earnout. McLerran & Associates negotiates the LOI on the owner’s behalf and pushes for less punitive earnout structures, including pro-rata provisions and metric definitions that the buyer cannot easily manipulate through post-close overhead allocations.
How To Price The Work-Back Before You Agree To It
A DSO deal typically requires the selling dentist to continue practicing under an employment agreement for three to six years post-close. A shorter work-back may be possible when the owner has already reduced chair time and associates carry a meaningful share of production, but it requires negotiation and is not the default. A private doctor-to-doctor walk-away sale typically involves a work-back of only about four to eight weeks, as noted earlier.
The work-back has a real cost. Divide the total after-tax proceeds by the hours of post-close clinical work required across the employment term, and the effective hourly return on those years becomes visible. That figure should be compared against what the owner would earn keeping the practice and taking distributions, a baseline McLerran & Associates models explicitly in its multi-structure financial forecasting.
Buyers scrutinize provider risk more heavily in 2026, and a seller unwilling to remain on board for three to five years faces increased scrutiny and potential multiple compression. That dynamic is real, yet the owner can still negotiate. The length, compensation structure, and termination provisions of the employment agreement all sit on the table.
How To Model The Tax Treatment Before You Sign
The purchase price allocation, meaning how the total consideration is divided across asset classes, can be one of the most consequential negotiated terms in any dental practice sale. It should be settled before the LOI is signed, not the week before closing. Under IRC §1060, both the seller and purchaser must report the allocation on IRS Form 8594, and a mismatch between the two filings can be a common audit trigger.
Goodwill, which typically represents more than 76% of the dental practice purchase price, is generally taxed at long-term capital gains rates. Equipment recapture is taxed as ordinary income under IRC §1245. Every dollar allocated to a non-compete covenant is also ordinary income to the seller. On a $3 million practice sale, every $100,000 shifted from a non-compete allocation to goodwill can save roughly $13,200 in federal taxes.
In a cash-plus-rollover deal, the cash component is taxed under the asset allocation at closing, while a properly structured rollover may defer recognition until a later taxable event. The rollover may not qualify for deferral if the structuring is skipped at the LOI stage. For a fuller treatment of these mechanics, see Dental Practice Transition Tax Implications Explained. This article is educational, so a qualified tax advisor should be consulted before signing any transaction documents.
How To Know If Your Buyer Is Private Equity-Backed And Create Competition
Identifying whether a buyer is private equity-backed starts with direct questions. Ask who the sponsor is, what the fund’s hold period is, and whether the buyer will disclose the capitalization structure, including the debt sitting above the seller’s equity. Request seller references from deals closed in the last 12 to 24 months and ask for a meaningful list rather than one or two anonymous names. Red flags include an undisclosed PE sponsor or vague ownership structure, time pressure to sign inside 30 days without a competitive process, and seller references limited to one or two anonymous sellers.
A single suitor has little reason to move on price or terms. Competitive tension can move cash-at-close. A formal competitive auction inviting multiple platform DSOs to bid on a dental practice can produce 15% to 40% higher multiples than a bilateral deal with a single suitor. McLerran & Associates runs a structured, auction-like bid process, typically about 45–60 days and generating around 10 offers, among a vetted, pre-qualified pool of buyers, with poorly run DSOs blacklisted. Clients often see roughly a 30% higher valuation than owners achieve selling on their own. For a broader look at how the two transition paths compare, see Dental Practice Transition Options: Private Sale vs. DSO.
Understanding the current market ranges can help you judge whether the offers in front of you are competitive. The next section outlines what dental practices are selling for in 2026.
How Much Are Dental Practices Selling For In 2026?
To put the cash-versus-equity tradeoff in context, it helps to know the broad valuation ranges buyers are working from in 2026. Dental practice valuations in 2026 vary considerably based on practice size, specialty, number of producing doctors, payer mix, EBITDA, and whether the buyer is an individual dentist or an institutional platform. Institutional buyers use EBITDA as the dominant valuation lens, while smaller owner-operated practices may be valued on collections or SDE, and those two methods can produce very different numbers for the same practice.
For individual dentist buyers, general-practice private sales can fall in the range of approximately 65%–85% of annual gross collections. For DSO and institutional buyers, dental practices broadly sell at 5x–11x adjusted EBITDA in 2026, with single-doctor and add-on practices clustering at the lower end of that range and emerging multi-location platforms at the higher end. Specialty practices can command different ranges depending on associate depth, referral concentration, and which buyer categories are actively competing for that specialty.
Several factors can move a multiple higher. These include several producing doctors, a strong hygiene schedule, a fee-for-service or commercial PPO payer mix, modern equipment, a secure lease with room to expand, and associate-led production that reduces key-person risk. Factors that can compress a multiple include heavy Medicaid exposure, aging equipment, a solo producer practice, and a short remaining lease term. These are general patterns, and your specific multiple is determined by your specific numbers, which is exactly what a diligence-grade valuation quantifies.
Frequently Asked Questions
How Long Does a Dental Practice Sale Take From Decision to Close?
A dental practice sale typically runs six to twelve months from engagement to closing, though the timeline can vary. Preparation and valuation generally take four to eight weeks. Marketing and offer collection can run six to twelve weeks in a structured competitive process. Due diligence and closing add another two to four months, with payer re-credentialing sometimes extending the timeline further.
DSO deals tend to run longer than private doctor-to-doctor sales because of the additional document complexity, including the purchase agreement, employment agreement, rollover equity documents, and management services agreement. Insurance credentialing for the new entity can take 60 to 180 days. Owners who begin the process with a diligence-grade valuation already in hand often move faster and with fewer surprises.
What Financial Inputs Does a Buyer Use to Value My Practice?
DSO and institutional buyers value dental practices on adjusted EBITDA. EBITDA is the practice’s earnings before interest, taxes, depreciation, and amortization, calculated after replacing the owner’s compensation with a market associate rate and adding back personal, discretionary, and non-recurring expenses. The most common add-backs include above-market owner compensation, family members on payroll at above-market rates, personal vehicle and club memberships, and one-time costs.
Individual dentist buyers more commonly value on a percentage of collections or a multiple of seller’s discretionary earnings. The two methods can produce very different numbers for the same practice. A CPA-led EBITDA analysis, done before going to market, can be some of the main factors that control the narrative and reduce the risk that the buyer’s quality-of-earnings team re-trades the deal during diligence.
What Is the Difference Between a DSO, a Private Equity Firm, and an Individual Dentist Buyer?
A DSO (Dental Service Organization) is an operating and support model. It provides management services, real estate, billing, HR, marketing, and purchasing to dentist-owned professional entities under a management services agreement. A private equity firm is a capital source, not an operating model. Many DSOs are private equity-backed, meaning a PE sponsor owns the DSO’s management company and provides the capital for acquisitions.
An individual dentist buyer is a licensed dentist purchasing the practice to operate it personally. Each buyer type produces a different deal structure, different rollover equity terms, different employment expectations, and different post-close operating environments. McLerran & Associates vets buyers across all three categories and steers owners toward well-backed, well-run partners with a track record of satisfied sellers.
What Happens to My Rollover Equity If I Leave or Retire?
What happens to rolled equity on departure depends entirely on the terms negotiated in the equityholders’ agreement and employment documents. There is no universal standard. Common provisions include vesting schedules under which unvested equity is forfeited on early departure, repurchase rights allowing the DSO to buy back the seller’s equity at a formula price, clawback provisions requiring the seller to return a portion of the initial cash payment if they leave before a defined date, and drag-along rights that can force the seller to sell their equity alongside the sponsor at the sponsor’s chosen time and price.
Disability and death are sometimes addressed through carve-outs in the non-compete, but their treatment in the equity documents varies. These terms should be reviewed as a coordinated package before signing the LOI.
How Do I Keep a Sale Confidential While Marketing the Practice?
Confidentiality in a dental practice sale requires a structured process from the start. A properly run sale uses blind marketing materials that describe the practice without identifying it, non-disclosure agreements executed before any financial information is shared, staged release of information as buyers qualify, and a communication plan agreed upon before any staff or patients are informed.
Staff and patients should hear about the sale from the owner after the deal is certain, rather than from rumors or third parties. McLerran & Associates manages this process on the owner’s behalf, acting as a buffer between seller and buyer to protect goodwill, staff relationships, and patient continuity throughout the transaction.
Conclusion: Compare Both Offers on Equal Footing
The headline price rarely reflects the full deal. A DSO offer usually needs to be reduced by taxes on the cash portion, discounted for the illiquidity and subordination of the equity, and charged for the years of post-close clinical work before it can sit next to an all-cash number. The equity the owner is asked to roll represents their own money reinvested at risk in a private platform, junior to debt, with liquidity controlled by the sponsor.
McLerran & Associates is the nation’s largest dental-specific sell-side M&A advisory and brokerage firm. The firm runs both the private-buyer and DSO paths in roughly equal measure, produces a diligence-grade CPA-led EBITDA valuation, and creates the competition, through a structured, auction-like bid process typically generating around 10 offers, that improves cash-at-close and terms. McLerran & Associates is sell-side only. Its client is always the practice owner, never the buyer.
Register for the McLerran M&A Summit, October 29–30, 2026.
